Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastrointestinal behavior of aprepitant in healthy volunteers
2016-001156-22Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aprepitant in Nausea and Vomiting (2 arms), sponsored by KU Leuven. Primary endpoint: Gastrointestinal behavior of aprepitant. Started Jun 2016; status: completed.
02
Drugs
aprepitant
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on 2016-001156-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001156-22.